 SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 GLOBE NEWSWIRE -- DICE Therapeutics, Inc. Nasdaq: DICE, a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, today announced management will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 p.m. PST 3:00 p.m. EST. 